Related Experiment Video
Updated: Jan 14, 2026

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice
Published on: November 27, 2019
Rationale and protocol for a randomized parallel intervention trial of two intermittent fasting approaches in
Felicia L Steger1, Joseph E Donnelly2, Robert N Montgomery3
1Division of Endocrinology, Diabetes, and Clinical Pharmacology and KU Diabetes Institute; Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA; Department of Dietetics and Nutrition, University of Kansas Medical Center, Kansas City, KS, USA; Kansas Center for Metabolism and Obesity Research, Kansas City, KS, USA.
Background:
Type 2 diabetes (T2D) is a progressive disease driven by insulin resistance and β-cell dysfunction, often exacerbated by excess body weight. Intermittent fasting (IF) approaches, including intermittent energy restriction (IER) and time-restricted eating (TRE), have shown promise for improving glycemic control and facilitating diabetes remission. However, the feasibility and effectiveness of these IF approaches in individuals with T2D remain underexplored.
Objective:
This study aims to compare the feasibility, acceptability, and metabolic effects of IER and TRE in a randomized parallel trial in adults with T2D.
Methods:
Adults with T2D (N = 56) and overweight/obesity will be randomized to one of two interventions: IER (550-800 kcal/day on 2-3 days/week) or TRE (caloric intake within an 8-h daily window). Both groups will receive a comprehensive, remotely delivered diabetes education and behavioral support program over 6 months, followed by a 6-month low-contact follow-up during which participants continued the intervention on their own. Primary outcomes include feasibility (recruitment, retention, adherence) and acceptability. Secondary outcomes include changes in HbA1c, insulin sensitivity, insulin response to a mixed-meal tolerance test, body composition, and diabetes remission. Continuous glucose monitoring, metabolic and behavioral phenotyping will inform predictors of response.
Conclusion:
This study is the first parallel trial to compare IER and TRE in patients with T2D and overweight/obesity. Results will provide critical data on the metabolic and behavioral responses to each IF approach, informing future strategies to personalize nutrition therapy in T2D.
More Related Videos
06:13Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...